CORE--GENE EXPRESSION

$198,687P01FY2007AGNIH

Albert Einstein College Of Medicine, Bronx NY

Investigators

Linked publications & trials

Paper 38850591 Paper 38439214 Paper 37137499 Paper 36843279 Paper 36453627 Paper 33756103 Paper 33089916 Paper 32762010 Paper 32575074 Paper 32333835 Paper 31695094 Paper 29921922 Paper 29765957 Paper 29739805 Paper 29705978 Paper 29321258 Paper 28705468 Paper 28630896 Paper 27377170 Paper 27304507 Paper 27304500 Paper 27260402 Paper 26677855 Paper 26637439 Paper 26534869 Paper 26334176 Paper 26142631 Paper 25426837 Paper 25245408 Paper 25203624 Paper 24997018 Paper 24842889 Paper 24509014 Paper 24383816 Paper 24350928 Paper 24037343 Paper 23349486 Paper 23089338 Paper 22859390 Paper 22847060 Paper 22618766 Paper 22460760 Paper 22056385 Paper 21896928 Paper 21812767 Paper 20703052 Paper 20504893 Paper 20497131 Paper 20194508 Paper 20126273 Paper 19706785 Paper 19623253 Paper 19417129 Paper 19364483 Paper 19208733 Paper 18566293 Paper 18363902 Paper 18073320 Paper 17911339 Paper 17677003 Paper 17273170 Paper 17237715 Paper 17213476 Paper 17190939 Paper 17099068 Paper 17003344 Paper 16741579 Paper 16731840 Paper 16604086 Paper 16528412 Paper 16528409 Paper 16413606 Paper 16249443 Paper 16168602 Paper 16081739 Paper 15856066 Paper 15735652 Paper 15734842 Paper 15536073 Paper 15272501 Paper 14969503

Abstract

The purpose of this Core is to provide efficient, quality-controlled, and cost-effective quantitation of gene expression by real-time PCR techniques to the investigators participating in this Program Project. The gene expression core will quantify hypothalamic neuropeptide expression for project by Rossetti, and fat-derived and cytokines for projects by Barzilai, Hawkins, Brownlee, and Shamoon. The quantitation of gene expression by real-time PCR will be centralized in a single facility and available to the investigators of this program. The personnel of this core will be responsible for running real time PCR and quality control testing of each experiment. They will also assist for the design of new speific primers. This core will be directed by Dr. Obici. Scheduling the priority for running tests will be decided by consent among the participants of the program.

View original record on NIH RePORTER →